Antiviral Abidol is Associated with the Reduction of In-Hospital Mortality in COVID-19 Patients

OBJECTIVE: Coronavirus disease 2019 (COVID-19) is a global public health crisis. There are no specific antiviral agents for the treatment of SARS-CoV-2. Information regarding the effect of Abidol on in-hospital mortality is scarce. The present study aimed to evaluate the treatment effect of Abidol f...

Descripción completa

Detalles Bibliográficos
Autores principales: Zeng, Hesong, He, Xingwei, Liu, Wanjun, Kan, Jing, He, Liqun, Zhao, Jinhe, Chen, Cynthia, Zhang, Junjie, Chen, Shaoliang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8710295/
https://www.ncbi.nlm.nih.gov/pubmed/34977907
http://dx.doi.org/10.1097/CD9.0000000000000014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8710295/
https://www.ncbi.nlm.nih.gov/pubmed/34977907
http://dx.doi.org/10.1097/CD9.0000000000000014

Ejemplares similares